By Jeff Overley ( May 1, 2017, 7:41 PM EDT) -- The Third Circuit on Monday nixed a False Claims Act suit accusing Genentech Inc. of defrauding Medicare by concealing side effects of its blockbuster cancer drug Avastin, saying a whistleblower didn't show that failing to report safety information was relevant to government reimbursement for the medication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.